News
Sage/Biogen's zuranolone works in depression, but maybe not ...
Sage Therapeutics and Biogen's antidepressant candidate zuranolone has hit its objectives in a phase 3 trial, but a falloff in efficacy over time has raised concerns about the commercial po
